Brief: Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule
20/08/2026 23:26
BRIEF-Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule Aug 20 (Reuters) - Atrium Therapeutics Inc RNA.O:
ATRIUM THERAPEUTICS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)
Source text: ID:nPnzXGlca
Further company coverage: RNA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Atrium Therapeutics
See all newsBrief: Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Yakira Capital Management Calls On Atrium Therapeutics To Launch Strategic Review
US STOCKS ON THE MOVE-Palantir, Haemonetics
U.S. STOCKS ON THE MOVE-Palantir, Haemonetics, Starbucks
Atrium Therapeutics rallies after $50 mln equity raise